Recursion Pharmaceuticals, Inc. financial data

Symbol
RXRX on Nasdaq
Location
41 S Rio Grande Street, Salt Lake City, UT
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 438 % +1.14%
Debt-to-equity 38.3 % -8.02%
Return On Equity -74.7 % +6.58%
Return On Assets -54 % +4.32%
Operating Margin -960 % -17.9%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 406M shares +71.1%
Entity Public Float 1.51B USD +62.1%
Common Stock, Value, Issued 4K USD +100%
Weighted Average Number of Shares Outstanding, Basic 403M shares +70.7%
Weighted Average Number of Shares Outstanding, Diluted 403M shares +70.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 59.8M USD +29.3%
Research and Development Expense 376M USD +43.6%
General and Administrative Expense 201M USD +68.8%
Costs and Expenses 634M USD +49.9%
Operating Income (Loss) -574M USD -52.5%
Nonoperating Income (Expense) -1.25M USD -107%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -575M USD -60.3%
Income Tax Expense (Benefit) -506K USD +89.5%
Net Income (Loss) Attributable to Parent -575M USD -62.3%
Earnings Per Share, Basic -2 USD/shares -10.4%
Earnings Per Share, Diluted -2 USD/shares -10.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 500M USD +68.9%
Other Assets, Current 32M USD -22.8%
Assets, Current 584M USD +70%
Deferred Income Tax Assets, Net 2M USD
Property, Plant and Equipment, Net 127M USD +46.3%
Operating Lease, Right-of-Use Asset 53.2M USD +49.8%
Intangible Assets, Net (Excluding Goodwill) 336M USD +915%
Goodwill 158M USD +204%
Other Assets, Noncurrent 14.8M USD +5718%
Assets 1.31B USD +134%
Accounts Payable, Current 25.1M USD +390%
Employee-related Liabilities, Current 22.5M USD +123%
Accrued Liabilities, Current 56.8M USD +118%
Contract with Customer, Liability, Current 39.7M USD +8.28%
Liabilities, Current 142M USD +92.1%
Long-term Debt and Lease Obligation 16.4M USD
Contract with Customer, Liability, Noncurrent 130M USD +247%
Deferred Income Tax Liabilities, Net 22.4M USD +4149%
Operating Lease, Liability, Noncurrent 56M USD +28%
Other Liabilities, Noncurrent 4.79M USD
Liabilities 371M USD +137%
Accumulated Other Comprehensive Income (Loss), Net of Tax 14.1M USD
Retained Earnings (Accumulated Deficit) -1.63B USD -54.3%
Stockholders' Equity Attributable to Parent 934M USD +133%
Liabilities and Equity 1.31B USD +134%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -132M USD -29%
Net Cash Provided by (Used in) Financing Activities 40.5M USD +192%
Net Cash Provided by (Used in) Investing Activities -7.27M USD -9.27%
Common Stock, Shares Authorized 2B shares 0%
Common Stock, Shares, Issued 406M shares +71.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -93.9M USD +1.48%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 509M USD +66.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 13K USD -7.14%
Deferred Tax Assets, Valuation Allowance 466M USD +53%
Deferred Tax Assets, Gross 541M USD +69.1%
Operating Lease, Liability 81M USD +63.6%
Depreciation 18.3M USD +15.1%
Payments to Acquire Property, Plant, and Equipment 1.83M USD -72.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -561M USD -58.3%
Lessee, Operating Lease, Liability, to be Paid 101M USD +52.9%
Property, Plant and Equipment, Gross 204M USD +55.1%
Operating Lease, Liability, Current 11.9M USD +95.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 20.5M USD +96.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 19.4M USD +92.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 20.1M USD +21.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 20.8M USD +97.7%
Deferred Tax Assets, Operating Loss Carryforwards 274M USD +133%
Unrecognized Tax Benefits 6.75M USD +24.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 16.8M USD +55.9%
Operating Lease, Payments 5.27M USD +33.1%
Additional Paid in Capital 2.55B USD +74.9%
Amortization of Intangible Assets 27.1M USD +131%
Depreciation, Depletion and Amortization 19.3M USD +162%
Deferred Tax Assets, Net of Valuation Allowance 75.2M USD +383%
Share-based Payment Arrangement, Expense 99.6M USD +69%
Interest Expense 98K USD +63.3%